Canada markets close in 3 hours 1 minute

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
36.60-0.09 (-0.25%)
As of 12:59PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.45B
Enterprise Value 1.07B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)334.78
Price/Book (mrq)3.65
Enterprise Value/Revenue 259.28
Enterprise Value/EBITDA -14.57

Trading Information

Stock Price History

Beta (5Y Monthly) 2.43
52-Week Change 3-21.70%
S&P500 52-Week Change 3-6.48%
52 Week High 357.20
52 Week Low 319.85
50-Day Moving Average 326.83
200-Day Moving Average 333.15

Share Statistics

Avg Vol (3 month) 3859.75k
Avg Vol (10 day) 3501.08k
Shares Outstanding 546.75M
Implied Shares Outstanding 6N/A
Float 841.2M
% Held by Insiders 10.21%
% Held by Institutions 1109.21%
Shares Short (Jul 14, 2022) 43.81M
Short Ratio (Jul 14, 2022) 42.93
Short % of Float (Jul 14, 2022) 49.61%
Short % of Shares Outstanding (Jul 14, 2022) 48.15%
Shares Short (prior month Jun 14, 2022) 44.71M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 10, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Feb 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-1,854.71%

Management Effectiveness

Return on Assets (ttm)-14.93%
Return on Equity (ttm)-26.01%

Income Statement

Revenue (ttm)4.14M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)-74.60%
Gross Profit (ttm)-48.66M
EBITDA -73.68M
Net Income Avi to Common (ttm)-77.02M
Diluted EPS (ttm)-1.73
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)380.47M
Total Cash Per Share (mrq)8.14
Total Debt (mrq)2.64M
Total Debt/Equity (mrq)0.66
Current Ratio (mrq)26.83
Book Value Per Share (mrq)8.52

Cash Flow Statement

Operating Cash Flow (ttm)-67.36M
Levered Free Cash Flow (ttm)-42.97M